Technical Analysis for CASI - CASI Pharmaceuticals, Inc.
|Grade||Last Price||% Change||Price Change|
CASI closed down 4.21 percent on Friday, January 18, 2019, on 60 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
|Weak or Absent||Down||Down||Down|
|See historical CASI trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||180 Bearish Setup||Bearish Swing Setup||0.00%|
|Jan 18||Inside Day||Range Contraction||0.00%|
|Jan 18||Oversold Stochastic||Weakness||0.00%|
|Jan 17||Hammer Candlestick||Bullish||-4.21%|
|Jan 17||Stochastic Buy Signal||Bullish||-4.21%|
|Jan 17||Lower Bollinger Band Touch||Weakness||-4.21%|
|Jan 17||Oversold Stochastic||Weakness||-4.21%|
|Jan 16||20 DMA Resistance||Bearish||-3.45%|
|Jan 16||50 DMA Resistance||Bearish||-3.45%|
|Jan 16||180 Bearish Setup||Bearish Swing Setup||-3.45%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. The company's lead drug candidate includes ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer, which has completed Phase I studies in patients with advanced solid tumors, multiple myeloma, and leukemia, as well as it is completing data for a multi-center Phase II study in patients with platinum resistant ovarian cancer. Its other product candidates in development include 2-methoxyestrdiol, an orally active compound for autoimmune diseases; and MKC-1, an orally-active cell cycle inhibitor that has completed Phase II clinical trials for cancer treatment. The company name was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Rockville, Maryland.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more CASI news...
|52 Week High||8.89|
|52 Week Low||2.73|
|200-Day Moving Average||5.7216|
|50-Day Moving Average||3.9605|
|20-Day Moving Average||4.015|
|10-Day Moving Average||3.894|
|Average True Range||0.2837|
|Chandelier Exit (Long, 3 ATRs )||3.7289|
|Chandelier Exit (Short, 3 ATRs )||4.3611|
|Upper Bollinger Band||4.443|
|Lower Bollinger Band||3.587|
|Percent B (%b)||0.06|
|MACD Signal Line||-0.031|
|Market Cap||219.12 Million|
|Num Shares||60.2 Million|
|Price-to-Earnings (P/E) Ratio||-28.00|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||3.96|
|Resistance 3 (R3)||3.98||3.91||3.90|
|Resistance 2 (R2)||3.91||3.83||3.89||3.88|
|Resistance 1 (R1)||3.77||3.78||3.74||3.75||3.87|
|Support 1 (S1)||3.56||3.62||3.53||3.54||3.41|
|Support 2 (S2)||3.49||3.57||3.47||3.40|
|Support 3 (S3)||3.35||3.49||3.38|
|Support 4 (S4)||3.33|